These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30583070)

  • 1. Rafoxanide, an organohalogen drug, triggers apoptosis and cell cycle arrest in multiple myeloma by enhancing DNA damage responses and suppressing the p38 MAPK pathway.
    Xiao W; Xu Z; Chang S; Li B; Yu D; Wu H; Xie Y; Wang Y; Xie B; Sun X; Kong Y; Lan X; Bu W; Chen G; Gao L; Wu X; Shi J; Zhu W
    Cancer Lett; 2019 Mar; 444():45-59. PubMed ID: 30583070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of rafoxanide as a dual CDK4/6 inhibitor for the treatment of skin cancer.
    Shi X; Li H; Shi A; Yao H; Ke K; Dong C; Zhu Y; Qin Y; Ding Y; He YH; Liu X; Li L; Lei L; Hai Q; Chen W; Leung KS; Wong MH; Kung HF; Lin MC
    Oncol Rep; 2018 Sep; 40(3):1592-1600. PubMed ID: 29956794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BIRB 796 enhances cytotoxicity triggered by bortezomib, heat shock protein (Hsp) 90 inhibitor, and dexamethasone via inhibition of p38 mitogen-activated protein kinase/Hsp27 pathway in multiple myeloma cell lines and inhibits paracrine tumour growth.
    Yasui H; Hideshima T; Ikeda H; Jin J; Ocio EM; Kiziltepe T; Okawa Y; Vallet S; Podar K; Ishitsuka K; Richardson PG; Pargellis C; Moss N; Raje N; Anderson KC
    Br J Haematol; 2007 Feb; 136(3):414-23. PubMed ID: 17173546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor effects of rafoxanide in diffuse large B cell lymphoma via the PTEN/PI3K/Akt and JNK/c-Jun pathways.
    He W; Xu Z; Song D; Zhang H; Li B; Gao L; Zhang Y; Feng Q; Yu D; Hu L; Chen G; Tao Y; Wu X; Shi J; Zhu W
    Life Sci; 2020 Feb; 243():117249. PubMed ID: 31926247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rafoxanide promotes apoptosis and autophagy of gastric cancer cells by suppressing PI3K /Akt/mTOR pathway.
    Liu JZ; Hu YL; Feng Y; Guo YB; Liu YF; Yang JL; Mao QS; Xue WJ
    Exp Cell Res; 2019 Dec; 385(2):111691. PubMed ID: 31678170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of p38alpha MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-X(L), Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivo.
    Navas TA; Nguyen AN; Hideshima T; Reddy M; Ma JY; Haghnazari E; Henson M; Stebbins EG; Kerr I; O'Young G; Kapoun AM; Chakravarty S; Mavunkel B; Perumattam J; Luedtke G; Dugar S; Medicherla S; Protter AA; Schreiner GF; Anderson KC; Higgins LS
    Leukemia; 2006 Jun; 20(6):1017-27. PubMed ID: 16617327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced anticancer efficacy of snake venom combined with silica nanoparticles in a murine model of human multiple myeloma: molecular targets for cell cycle arrest and apoptosis induction.
    Al-Sadoon MK; Rabah DM; Badr G
    Cell Immunol; 2013; 284(1-2):129-38. PubMed ID: 23973876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artesunate induces ROS- and p38 MAPK-mediated apoptosis and counteracts tumor growth in vivo in embryonal rhabdomyosarcoma cells.
    Beccafico S; Morozzi G; Marchetti MC; Riccardi C; Sidoni A; Donato R; Sorci G
    Carcinogenesis; 2015 Sep; 36(9):1071-83. PubMed ID: 26153023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel herbal formula induces cell cycle arrest and apoptosis in association with suppressing the PI3K/AKT pathway in human lung cancer A549 cells.
    Xiong F; Jiang M; Huang Z; Chen M; Chen K; Zhou J; Yin L; Tang Y; Wang M; Ye L; Zhan Z; Duan J; Fu H; Zhang X
    Integr Cancer Ther; 2014 Mar; 13(2):152-60. PubMed ID: 24105357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evodiamine induces apoptosis and inhibits metastasis in MDA‑MB-231 human breast cancer cells in vitro and in vivo.
    Du J; Wang XF; Zhou QM; Zhang TL; Lu YY; Zhang H; Su SB
    Oncol Rep; 2013 Aug; 30(2):685-94. PubMed ID: 23708383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel M phase blocker, DCZ3301 enhances the sensitivity of bortezomib in resistant multiple myeloma through DNA damage and mitotic catastrophe.
    Hu L; Li B; Chen G; Song D; Xu Z; Gao L; Xi M; Zhou J; Li L; Zhang H; Feng Q; Wang Y; Lu K; Lu Y; Bu W; Wang H; Wu X; Zhu W; Shi J
    J Exp Clin Cancer Res; 2020 Jun; 39(1):105. PubMed ID: 32517809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P38 MAPK inhibition enhancing ATO-induced cytotoxicity against multiple myeloma cells.
    Wen J; Cheng HY; Feng Y; Rice L; Liu S; Mo A; Huang J; Zu Y; Ballon DJ; Chang CC
    Br J Haematol; 2008 Jan; 140(2):169-80. PubMed ID: 18173754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of endoplasmic reticulum stress and inhibition of colon carcinogenesis by the anti-helmintic drug rafoxanide.
    Laudisi F; Di Grazia A; De Simone V; Cherubini F; Colantoni A; Ortenzi A; Franzè E; Dinallo V; Di Fusco D; Monteleone I; Fearon ER; Monteleone G; Stolfi C
    Cancer Lett; 2019 Oct; 462():1-11. PubMed ID: 31351087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calmodulin antagonists induce cell cycle arrest and apoptosis in vitro and inhibit tumor growth in vivo in human multiple myeloma.
    Yokokura S; Yurimoto S; Matsuoka A; Imataki O; Dobashi H; Bandoh S; Matsunaga T
    BMC Cancer; 2014 Nov; 14():882. PubMed ID: 25424011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The blueberry component pterostilbene has potent anti-myeloma activity in bortezomib-resistant cells.
    Chen G; Xu Z; Chang G; Hou J; Hu L; Zhang Y; Yu D; Li B; Chang S; Xie Y; Zhang Y; Wei R; Wu H; Xiao W; Sun X; Tao Y; Gao L; Dai B; Shi J; Zhu W
    Oncol Rep; 2017 Jul; 38(1):488-496. PubMed ID: 28560392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-Mangostin induces mitochondrial dependent apoptosis in human hepatoma SK-Hep-1 cells through inhibition of p38 MAPK pathway.
    Hsieh SC; Huang MH; Cheng CW; Hung JH; Yang SF; Hsieh YH
    Apoptosis; 2013 Dec; 18(12):1548-60. PubMed ID: 23912717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of Deubiquitylating Enzyme USP1 Inhibits DNA Repair and Triggers Apoptosis in Multiple Myeloma Cells.
    Das DS; Das A; Ray A; Song Y; Samur MK; Munshi NC; Chauhan D; Anderson KC
    Clin Cancer Res; 2017 Aug; 23(15):4280-4289. PubMed ID: 28270494
    [No Abstract]   [Full Text] [Related]  

  • 18. Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways.
    Kobayashi T; Kuroda J; Ashihara E; Oomizu S; Terui Y; Taniyama A; Adachi S; Takagi T; Yamamoto M; Sasaki N; Horiike S; Hatake K; Yamauchi A; Hirashima M; Taniwaki M
    Leukemia; 2010 Apr; 24(4):843-50. PubMed ID: 20200560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DCZ0801, a novel compound, induces cell apoptosis and cell cycle arrest via MAPK pathway in multiple myeloma.
    Zhang T; Li B; Feng Q; Xu Z; Huang C; Wu H; Chen Z; Hu L; Gao L; Liu P; Yang G; Zhang H; Lu K; Li T; Tao Y; Wu X; Shi J; Zhu W
    Acta Biochim Biophys Sin (Shanghai); 2019 May; 51(5):517-523. PubMed ID: 30947332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-proliferation and anti-metastasis effect of barbaloin in non-small cell lung cancer via inactivating p38MAPK/Cdc25B/Hsp27 pathway.
    Zhang Z; Rui W; Wang ZC; Liu DX; Du L
    Oncol Rep; 2017 Aug; 38(2):1172-1180. PubMed ID: 28656293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.